Importance Postauthorization monitoring of vaccines in a large population may detect rare
adverse events not identified in clinical trials such as Guillain-Barré syndrome (GBS), which …

Objective To identify the rates of neurological events following administration of mRNA
(Pfizer, Moderna) or adenovirus vector (Janssen) vaccines in the US Methods We used …

Guillain Barré syndrome (GBS) and its variants, and chronic inflammatory demyelinating
polyradiculoneuropathy (CIDP and its variants, are regarded as immune mediated …

Background Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is
associated with disorders affecting the peripheral and the central nervous system. A high …

Miller-Fisher syndrome (MFS) is a rare variant of Guillain–Barré syndrome (GBS)
manifesting as the triad of ataxia, areflexia, and ophthalmoplegia. With the extensive 2019 …

Background and Objectives Infections play a key role in the development of Guillain-Barré
syndrome (GBS) and have been associated with specific clinical features and disease …

Background and Objective Little is known about trajectories of recovery 12 months after
hospitalization for severe COVID-19. Methods We conducted a prospective, longitudinal …

Background and purpose Many single cases and small series of Guillain–Barré syndrome
(GBS) associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) …

Background Persistent cognitive symptoms have been reported following COVID-19
hospitalization. We investigated the relationship between demographics, social …

Background and Objectives The clinical course and outcome of the Guillain-Barré syndrome
(GBS) are diverse and vary among regions. The modified Erasmus GBS Outcome Score …